Crescent Biopharma, Inc. (NASDAQ:CBIO – Get Free Report) COO Jonathan McNeill sold 3,839 shares of the business’s stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $16.71, for a total value of $64,149.69. Following the completion of the transaction, the chief operating officer directly owned […]

Crescent Biopharma, Inc. (NASDAQ:CBIO – Get Free Report) insider Ellie Im sold 623 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $17.90, for a total value of $11,151.70. Following the completion of the sale, the insider owned 21,446 shares of […]

Crescent Biopharma, Inc. (NASDAQ:CBIO – Get Free Report) CEO Joshua Brumm sold 1,610 shares of the firm’s stock in a transaction dated Wednesday, September 16th. The stock was sold at an average price of $17.90, for a total value of $28,819.00. Following the transaction, the chief executive officer owned 279,602 shares of the company’s stock, […]

Crescent Biopharma, Inc. (NASDAQ:CBIO – Get Free Report) CEO Joshua Brumm sold 7,837 shares of the business’s stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $16.71, for a total transaction of $130,956.27. Following the sale, the chief executive officer directly owned 271,765 shares in the company, […]